Hot Features
Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) acro... Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.4 | -16.7364016736 | 2.39 | 2.4998 | 1.77 | 55756 | 2.06371411 | CS |
| 4 | -0.94 | -32.0819112628 | 2.93 | 3.2 | 1.71 | 51049 | 2.43567225 | CS |
| 12 | -1.8 | -47.4934036939 | 3.79 | 4.05 | 1.71 | 26647 | 2.77469783 | CS |
| 26 | -3.76 | -65.3913043478 | 5.75 | 6.645 | 1.71 | 28142 | 3.91046203 | CS |
| 52 | -4.79 | -70.6489675516 | 6.78 | 9.5 | 1.71 | 193018 | 6.54556092 | CS |
| 156 | 0.7 | 54.2635658915 | 1.29 | 36 | 0.2914 | 505232 | 3.53377297 | CS |
| 260 | 0.45 | 29.2207792208 | 1.54 | 36 | 0.0846 | 1808528 | 0.87866175 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.